Cargando…
Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma
Mutations in the isocitrate dehydrogenase gene (IDH1) are involved in the progression of tumors. Although IDH1 has a role in various tumors, its clinical relevance and its expression in response to the immune response have not been investigated in prostate adenocarcinoma (PRAD). In the present study...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817883/ https://www.ncbi.nlm.nih.gov/pubmed/35132321 http://dx.doi.org/10.1155/2022/9854788 |
_version_ | 1784645736007204864 |
---|---|
author | Wen, Chen-Yueh Tsui, Kuan-Hao Chang, Chiung-Hung Chiu, Yi-Han Lin, Shu-Chuan Amy Chu, Ching-Yu Li, Chia-Jung |
author_facet | Wen, Chen-Yueh Tsui, Kuan-Hao Chang, Chiung-Hung Chiu, Yi-Han Lin, Shu-Chuan Amy Chu, Ching-Yu Li, Chia-Jung |
author_sort | Wen, Chen-Yueh |
collection | PubMed |
description | Mutations in the isocitrate dehydrogenase gene (IDH1) are involved in the progression of tumors. Although IDH1 has a role in various tumors, its clinical relevance and its expression in response to the immune response have not been investigated in prostate adenocarcinoma (PRAD). In the present study, we investigated the utility of IDH1 as a prognostic biomarker for PRAD by analyzing IDH1 mRNA expression and its association with patient survival and immune cell infiltration. IDH1 mRNA expression was significantly higher in PRAD tissue than in normal tissue, and Kaplan–Meier survival analysis showed that IDH1 expression was significantly associated with poor prognosis in PRAD patients. To elucidate the mechanisms involved, the correlation between IDH1 expression and the level of immune cell infiltration, in particular of immunosuppressive cells such as CD8+ T-cells, CD4+ T-cells, and macrophages, was further analyzed by single-cell RNA sequencing. We also screened a pharmacogenetic database for IDH1-specific drugs that inhibited high expression in PRAD. In the present study, we used a combination of databases to identify a significant correlation between IDH1 expression and cellular infiltration and to explain the mechanism by which IDH1 confers poor prognosis in PRAD, thus demonstrating the relevance of IDH1 expression as a prognostic biomarker with clinical utility in PRAD patients. |
format | Online Article Text |
id | pubmed-8817883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-88178832022-02-06 Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma Wen, Chen-Yueh Tsui, Kuan-Hao Chang, Chiung-Hung Chiu, Yi-Han Lin, Shu-Chuan Amy Chu, Ching-Yu Li, Chia-Jung J Oncol Research Article Mutations in the isocitrate dehydrogenase gene (IDH1) are involved in the progression of tumors. Although IDH1 has a role in various tumors, its clinical relevance and its expression in response to the immune response have not been investigated in prostate adenocarcinoma (PRAD). In the present study, we investigated the utility of IDH1 as a prognostic biomarker for PRAD by analyzing IDH1 mRNA expression and its association with patient survival and immune cell infiltration. IDH1 mRNA expression was significantly higher in PRAD tissue than in normal tissue, and Kaplan–Meier survival analysis showed that IDH1 expression was significantly associated with poor prognosis in PRAD patients. To elucidate the mechanisms involved, the correlation between IDH1 expression and the level of immune cell infiltration, in particular of immunosuppressive cells such as CD8+ T-cells, CD4+ T-cells, and macrophages, was further analyzed by single-cell RNA sequencing. We also screened a pharmacogenetic database for IDH1-specific drugs that inhibited high expression in PRAD. In the present study, we used a combination of databases to identify a significant correlation between IDH1 expression and cellular infiltration and to explain the mechanism by which IDH1 confers poor prognosis in PRAD, thus demonstrating the relevance of IDH1 expression as a prognostic biomarker with clinical utility in PRAD patients. Hindawi 2022-01-29 /pmc/articles/PMC8817883/ /pubmed/35132321 http://dx.doi.org/10.1155/2022/9854788 Text en Copyright © 2022 Chen-Yueh Wen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wen, Chen-Yueh Tsui, Kuan-Hao Chang, Chiung-Hung Chiu, Yi-Han Lin, Shu-Chuan Amy Chu, Ching-Yu Li, Chia-Jung Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title | Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title_full | Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title_fullStr | Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title_full_unstemmed | Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title_short | Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma |
title_sort | integrative multiomics evaluation of iidh1 metabolic enzyme as a candidate oncogene that is correlated with poor prognosis and immune infiltration in prostate adenocarcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817883/ https://www.ncbi.nlm.nih.gov/pubmed/35132321 http://dx.doi.org/10.1155/2022/9854788 |
work_keys_str_mv | AT wenchenyueh integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT tsuikuanhao integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT changchiunghung integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT chiuyihan integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT linshuchuanamy integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT chuchingyu integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma AT lichiajung integrativemultiomicsevaluationofiidh1metabolicenzymeasacandidateoncogenethatiscorrelatedwithpoorprognosisandimmuneinfiltrationinprostateadenocarcinoma |